Laboratory Testing Business — Business Valuation Multiple
EBITDA Valuation Guide · Small & Mid-Sized Businesses
Actual EBITDA multiples can vary materially based on EBITDA size, growth, recurring revenue, margins, customer concentration, owner dependence, geography and other company-specific factors.
Min
4×
Typical
6×
Max
8×
Revenue Model
Recurring
Capital Intensity
High
A typical multiple of 6× EBITDA reflects mid-market transactions in the $1–$50M revenue range.
Overview
Laboratory testing businesses typically trade at 4×–8× EBITDA. UKAS accreditation or equivalent, long-term testing contracts with regulated industries, and a diversified analytical portfolio support premium valuations. Specialist environmental, food, pharmaceutical, or construction testing capability creates meaningful barriers to entry. Equipment capex and specialist chemist recruitment are the primary risk factors.
Key Value Drivers
- UKAS or equivalent accreditation
- Long-term testing contracts with regulated industries
- Specialist environmental, food or pharmaceutical testing
- High switching costs in regulated supply chains
- Automation and throughput investment
Key Risks
- Equipment capex and calibration investment
- Specialist chemist and scientist recruitment
- Accreditation audit and compliance
- Single sector concentration
- Regulatory change in testing standards
Related Industries
Disclaimer: All multiples are indicative estimates only and are not formal valuations or investment advice. They should not be relied upon for financial decision-making without independent professional advice.